Insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls

Obesity Surgery

Volumn 24, Issue 3, 2014, Pages 349-358

  Dawson, Alison J ^a   Sathyapalan, Thozhukat ^b   Sedman, Peter ^c   Ajjan, Ramzi ^d   Kilpatrick, Eric S ^e   Atkin, Stephen L ^b  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Endothelial function; Insulin resistance; Obesity; Roux en Y surgery

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD CLOT LYSIS; BLOOD CLOTTING; BODY MASS; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; ENDOTHELIAL FUNCTION; EUGLOBULIN LYSIS TEST; FEMALE; FINAL TURBIDITY; GASTROINTESTINAL STAPLER; HIP CIRCUMFERENCE; HUMAN; INSULIN RESISTANCE; MALE; MAXIMUM ABSORBANCE; MORBID OBESITY; OBSERVATIONAL STUDY; OROGASTRIC TUBE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; ROUX EN Y BARIATRIC SURGERY; STOMACH TUBE; SURGICAL INFECTION; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; CARDIOVASCULAR DISEASES; COMORBIDITY; FASTING; FEMALE; FIBRINOLYSIS; GASTRIC BYPASS; HUMANS; INSULIN RESISTANCE; LAPAROSCOPY; MALE; OBESITY, MORBID; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84898050271     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-1100-2     Document Type: Article

References (51)

1. Obesity and overweight. 2006, World Health Organisation.
2. Felber JP. From obesity to diabetes. Pathophysiological considerations. Int J Obes Relat Metab Disord. 1992;16(12):937-52.
3. Huang Z et al. Bodyweight, weight change, and risk for hypertension in women. Ann Intern Med. 1998;128(2):81-8. (Pubitemid 28053128)
4. Wilson PW et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162(16):1867-72.
5. Calle EE et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625-38. (Pubitemid 36459468)
6. Solomon CG, Manson JE. Obesity and mortality: a review of the epidemiologic data. Am J Clin Nutr. 1997;66(4 Suppl):1044S-50S. (Pubitemid 27418746)
7. Buchwald H et al. Bariatric surgery: a systematic review and metaanalysis. JAMA. 2004;292(14):1724-37. (Pubitemid 39346675)
8. Adams TD et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753-61. (Pubitemid 47295642)
9. Mun EC, Blackburn GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology. 2001;120(3):669-81. (Pubitemid 32171639)
10. Kannel WB. Range of serum cholesterol values in the population developing coronary artery disease. Am J Cardiol. 1995;76(9): 69C-77C.
11. Koenig W et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999;99(2): 237-42. (Pubitemid 29056365)
12. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23 Suppl 1):III27-32. (Pubitemid 38786440)
13. Fatah K et al. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost. 1996;76(4):535-40. (Pubitemid 26372007)
14. Dunn EJ, Ariens RA, Grant PJ. The influence of type 2 diabetes on fibrin structure and function. Diabetologia. 2005;48(6):1198-206. (Pubitemid 40909657)
15. Mills JD et al. Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation. 2002;106(15):1938-42. (Pubitemid 35176298)
16. Alzahrani SH et al. Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers. J Clin Endocrinol Metab. 2012;97(12):E2282-7.
17. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-607. (Pubitemid 19004941)
18. Lindsay RS, Howard BV. Cardiovascular risk associated with the metabolic syndrome. Curr Diab Rep. 2004;4(1):63-8. (Pubitemid 39359512)
19. Ferrannini E, Mingrone G. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care. 2009;32(3):514-20.
20. Kellum JMet al. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg. 1990;211(6):763-70. discussion 770-1.
21. Korner J et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 2005;90(1):359-65. (Pubitemid 40116682)
22. Obesity guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. NICE clinical guideline 43 2006; Available from: http://guidance.nice.org. uk/CG43/NICEGuidance/pdf/English.
23. Carter AM et al. Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Arterioscler Thromb Vasc Biol. 2007;27(12):2783-9. (Pubitemid 350158937)
24. Dhabuwala A, Cannan RJ, Stubbs RS. Improvement in comorbidities following weight loss from gastric bypass surgery. Obes Surg. 2000;10(5):428-35.
25. Cowan Jr GS, Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg. 1998;22(9):987-92. (Pubitemid 28374618)
26. Gokce N et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol. 2005;95(2):266-8. (Pubitemid 40092098)
27. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285(19): 2486-97.
28. Park YW et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163(4):427-36.
29. Ruderman N et al. The metabolically obese, normal-weight individual revisited. Diabetes. 1998;47(5):699-713. (Pubitemid 28201798)
30. Wei M et al. Waist circumference as the best predictor of noninsulin dependent diabetesmellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americansa 7-year prospective study. Obes Res. 1997;5(1):16-23. (Pubitemid 127702765)
31. Polyzogopoulou EV et al. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes. 2003;52(5):1098-103. (Pubitemid 36523342)
32. Levitan EB et al. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med. 2004;164(19):2147-55. (Pubitemid 39410805)
33. Kitta Y, et al. Insulin resistance negatively affects long-term outcome in non-diabetic patients with coronary artery disease after therapies to reduce atherosclerotic risk factors. J Cardiol. 2013.
34. Carson JL et al. The effect of gastric bypass surgery on hypertension in morbidly obese patients. Arch Intern Med. 1994;154(2):193-200. (Pubitemid 24032193)
35. Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol. 2000;85(2):251-5. (Pubitemid 30026111)
36. Vazquez LA et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005;90(1): 316-22. (Pubitemid 40116674)
37. Ayer JG et al. Postprandial vascular reactivity in obese and normal weight young adults. Obesity (Silver Spring). 2010;18(5):945-51.
38. Juonala M et al. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation. 2004;110(18): 2918-23. (Pubitemid 39473618)
39. Puddu P et al. Different effects of antihypertensive drugs on endothelial dysfunction. Acta Cardiol. 2004;59(5):555-64. (Pubitemid 39331229)
40. Diamanti-Kandarakis E et al. Metformin administration improves endothelial function in women with polycystic ovary syndrome. Eur J Endocrinol. 2005;152(5):749-56. (Pubitemid 40744544)
41. Davis N, Katz S, Wylie-Rosett J. The effect of diet on endothelial function. Cardiol Rev. 2007;15(2):62-6.
42. Jones LC, Hingorani AD. Genetic regulation of endothelial function. Heart. 2005;91(10):1275-7. (Pubitemid 41360939)
43. Undas A, Ariens RA. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol. 2011;31(12):e88-99.
44. Primrose JN et al. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity. Thromb Haemost. 1992;68(4):396-9.
45. Pardina E, et al. Alterations in the common pathway of coagulation during weight loss induced by gastric bypass in severely obese patients. Obesity (Silver Spring); 2011.
46. Alessi MC, Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost. 2008;99(6):995-1000. (Pubitemid 351810479)
47. DiGiorgi M et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6(3):249-53.
48. Laurino Neto RM et al. Comorbidities remission after Roux-en-Y gastric bypass for morbid obesity is sustained in a long-term followup and correlates with weight regain. Obes Surg. 2012;22(10):1580-5.
49. Bonetti PO et al. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44(11):2137-41. (Pubitemid 39576032)
50. Vitale C et al. Metformin improves endothelial function in patients with metabolic syndrome. J Intern Med. 2005;258(3):250-6. (Pubitemid 41243057)
51. Renier G, Mamputu JC, Serri O. Benefits of gliclazide in the atherosclerotic process: decrease inmonocyte adhesion to endothelial cells. Metabolism. 2003;52(8 Suppl 1):13-8. (Pubitemid 37098384)